MPM BIOVENTURES V L.P. 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-06-26 3:27 pm Sale | 2020-06-24 | 13D | Rhythm Pharmaceuticals, Inc. RYTM | MPM BIOVENTURES V L.P. | 1,934,558 4.400% | -468,939 (-19.51%) | Filing |